Test Strip Market Research Report- Forecast to 2027

Test Strip Market by Application (Diagnosis {Urinalysis [UTI, Liver Disease]} Pregnancy Test) Type (Fluorescein, Diabetic Strips, Urine test strip) End Users (Consumers, Hospitals, Clinics, Diagnostic Laboratories) - Volume & Value - Forecast to 2027

ID: MRFR/MED/0201-HCR | August 2022 | Region: Global | 150 Pages         

Table of Content
1 Introduction

1.1 Definition

1.2 Scope of the study

1.2.1 Research Objectives

1.2.2 Assumptions & Limitations

1.3 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

2.4 Forecast Model

3 Report Excerpt

4 Forecast Indicators

4.1 Introduction

4.2 Growth Drivers

4.2.1 Government's Support

4.2.2 Technological advancements

4.2.3 High prevalence of UTIs

4.2.4 Rising diabetic population

4.2.5 Technological advancements

4.2.6 Players engaged in creating awareness

4.3 Growth Barriers

4.3.1 Varied regulatory stringency across globe

4.3.2 Lower rate of adoption in under developed countries

4.3.3 Inadequate reimbursement for test strips

4.4 Market Opportunities

4.4.1 Rising Point of Care

4.4.2 Rising Disposable Income Of Emerging Economies

4.5 Macroecnomical Indicators

5 Market Analysis

5.1 Marketing Mix

5.2 Porter's Five Force

5.3 Supply Chain Analysis

5.4 Value chain Analysis

6 Global Test Strip Markets, By Product Type

6.1 Introduction

6.2 Urine test strip

6.3 Diabetic Strips

6.4 Fluorescein

7 Global Test Strip Market, By Application

7.1 Introduction

7.2 Disease Diagnosis

7.2.1 Urinalysis Urinary Tract Infection (UTI) Liver Disease Kidney Diseases Diabetic Test Others

7.2.2 Blood Glucose Analysis

7.2.3 Ophthalmic Diagnostic

7.3 Pregnancy Test

8 Global Test Strip Market, By Function

8.1 Introduction

8.2 Visual Test Strips

8.3 Automated Test Strips

9 Global Test Strip Market, By End Users

9.1 Introduction

9.2 Institutes & Research Laboratories

9.3 Hospitals & Clinics

9.4 Diagnostic Laboratories

9.5 Consumers

10 Global Test Strip Market, by Region

10.1 Introduction

10.2 North America

10.2.1 U.S.

10.2.2 Canada

10.3 Europe

10.3.1 Germany

10.3.2 France

10.3.3 U.K.

10.3.4 Italy

10.3.5 Spain

10.3.6 Rest of Europe

10.4 Asia

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Rest of Asia

10.5 Rest of the World

11 Competitive Landscape

11.1 Market Share Analysis

11.1.1 Global

11.1.2 North America

11.1.3 Europe

11.1.4 Asia-Pacific

11.1.5 Rest of the World

11.2 Competitive/Strategic Scenario

11.2.1 Mergers Acquisitions

11.2.2 Collaborations

11.2.3 Expansion

11.2.4 New Product Launches

12 Company Profiles

12.1 Introduction

12.2 Abbott Laboratories

12.2.1 Overview

12.2.2 Financials

12.2.3 Product Portfolio

12.2.4 Recent Developments

12.2.5 Business Strategies

12.3 Arkray Inc.

12.3.1 Overview

12.3.2 Financials

12.3.3 Product Portfolio

12.3.4 Recent Developments

12.3.5 Business Strategies

12.4 Ascensia Diabetes Care Holdings Ag (Previously Known As Bayer Diabetes Care)

12.4.1 Overview

12.4.2 Financials

12.4.3 Product Portfolio

12.4.4 Recent Developments

12.4.5 Business Strategies

12.5 B. Braun Melsungen AG

12.5.1 Overview

12.5.2 Financials

12.5.3 Product Portfolio

12.5.4 Recent Developments

12.5.5 Business Strategies

12.6 Chiltern Medicare Ltd

12.6.1 Overview

12.6.2 Financials

12.6.3 Product Portfolio

12.6.4 Recent Developments

12.6.5 Business Strategies

12.7 Henry Schein

12.7.1 Overview

12.7.2 Financials

12.7.3 Product Portfolio

12.7.4 Recent Developments

12.7.5 Business Strategies

12.8 Lifeassay Diagnostics (Pty)

12.8.1 Overview

12.8.2 Financials

12.8.3 Product Portfolio

12.8.4 Recent Developments

12.8.5 Business Strategies

12.9 Lifescan, Inc. (a Johnson & Johnson company)

12.9.1 Overview

12.9.2 Financials

12.9.3 Product Portfolio

12.9.4 Recent Developments

12.9.5 Business Strategies

12.10 Roche Diagnostics

12.10.1 Overview

12.10.2 Financials

12.10.3 Product Portfolio

12.10.4 Recent Developments

12.10.5 Business Strategies

12.11 Siemens Healthcare

12.11.1 Overview

12.11.2 Financials

12.11.3 Product Portfolio

12.11.4 Recent Developments

12.11.5 Business Strategies

12.12 Taidoc Technology Corporation

12.12.1 Overview

12.12.2 Financials

12.12.3 Product Portfolio

12.12.4 Recent Developments

12.12.5 Business Strategies

12.13 Teco Diagnostics

12.13.1 Overview

12.13.2 Financials

12.13.3 Product Portfolio

12.13.4 Recent Developments

12.13.5 Business Strategies

Test Strip Market

The Test Strip Market growth rate for the forecast period. The test strips are thin paper or plastic strip that is used for various medical applications


By Application Pregnancy Test Urinal Analysis Florurescin Diabetic Strip
By End-User Consumers Hospitals Clinics Diagnostic Laboratories

Key Players

  • Abbott
  • Life scan
  • Tiadoc
  • Acon
  • B Braun
  • Siemens
  • Roche
  • Bayer
  • Arkray


  • Government's Support in various healthcare sectors
  • High prevalence of incidences of UTIs
  • Rising Diabetic Population
  • and various Technological advancements
Speak to Analyst Request a Free Sample

Test Strip Market Overview

The test strip market growth rate for the forecast period. The test strips are thin paper or plastic strip that is used for various medical applications. The fabric of these strips contains enzymes, sensor and electrodes. Also, it is a composition of several layers used for various purposes. There is a top player that acts as a sponge to soak blood. The middle layer is a filter and the third layer consists of enzymes. The bottom layers of the strips contain materials such as palladium and gold. 

The reaction of this electron material can transform the substance for analysis. The test strip market is gaining more traction in recent years. It is crucial applications are for diabetes, pregnancy test and other diagnoses. The international diabetes institution says that 7million individuals have diabetes. The increasing rate of these disorders is raising the demand for the test strip market.

The strips is used for extracting blood, filtering and analyzing the results is possible. The glucose strips is a segment of the market having immense demand. More supply of this product is accepted to boost the overall growth. Diagnostic laboratories and hospitals are the key end-users for the market. The demand rate is constantly surging from these verticals. The test strip market forecast shows all these factors can increase the market value in the forecast period. 

Covid analysis 

The impact of covid 19 is massive in most industries. The demand for test strips is considerably low in hospitals. Most of the patients were only allowed treatment for covid care. Other treatments were delayed in many hospitals. Especially, hospitals are restricting the visit of diabetes patients. Due to the fewer visits of the diabetes population in hospitals, the demand for test drips is slowing down.

However, most diabetes patients received treatment from home. The growth of smartphones and online treatment options sustains the market demand. The purchase of test strips online has increased during the pandemic. Most diabetes patients and pregnant women required test strips at home. Due to these factors, the growth and supply rate remains substantial. However, with less spread of the virus, the hospitals will have tremendous demand for test strips. 

Market dynamics 

  • Crucial market drivers 

Governmental support in the health sector is a crucial driver for the test strip market. Today, the governmental initiative for the improvement of health infrastructure is higher. The government is raising its investments in the health industry. The equipment and products required in health industries will have more demand. Especially, the diseases with high patient’s rates are given higher attention. Test strips are curial equipment for various diseases. Especially, they are used to detect diabetes and much more disorders in individuals. Due to this, the demand and awareness for the product will rise. In the next few years, mostly very health facilities will have est. strips.

Additionally, the prevalence of chronic illness is raising the adoption of test strips. Urinary infections, kidney disorders are leading to high growth in the test strip market. The intake of alcohol is the key reason for these disorders. However, through the test strips identifying these conditions are higher. Urbanisation in many regions is leading to a high population in cities. It leads to, more patients visiting hospitals. Most of these patients have an illness that requires the use of test strips. These crucial divers of the test strip market will contribute to the high growth of the test strip market size. 

  • The market growth opportunities 

The increasing demand for glucose test strips will lead to exceptional growth opportunities. Today, the Glucometers are highly beneficial for many patients. The convenience of Glucometers is high. The blood sugar levels are easily detectable through the Glucometers. However, type 1 diabetes patients can detect the sugar level effortlessly. Type 2 diabetes requires more testing to avoid complications. It is leading to higher adoption of glucose test strips by type 2 diabetes patients.

The increasing rate of diabetes conditions in upcoming years will lead to high demand for test strips. This surging diabetes patient’s rate will create exceptional growth prospects in the market. Significant research and development in the market will lead to high growth opportunities. The technological innovations and investments in the market will lead to high expansion. Also, new product launches will lead to high test strip market growth.

  • The market restraints 

The stringent governmental policies are restraining factors of the market. There are test strips available globally. However, there are only a few reliable and approved test strips. Due to these many generic strips, regulatory norms are high for the market. Getting approval for new strips may lead to high time consumption and delay. The strict norms of the market affect the supply and production of the market.

Lack of reimbursement policies for the test strip procedure in many regions is another growth restricting factor. The process of using test strips to detect chronic illness is expansive. However, the lack of reimbursement for this test is a limitation for the market. It may change the patient’s preference to other cost-effective strips. All these restraints can have slight effects on the overall market. 

  • The market challenges 

Sometimes, the results of the test strips may be accurate. Mostly these test strips can offer quality and reliable results. However, in some cases lack o accuracy on test results leads to various complications. This is a significant challenge in the test strip market. This creates a dilemma in patients to rely on test strip results or not.

Due to this transition of demand for other alternatives can affect the market. Further, the lack of awareness of many chronic diseases is another challenging factor of the test strip market. Due to a lack of disease awareness, the adoption of the test strip is less. Less awareness about this test can hamper test strip market expansion massively. 

  • The cumulative growth analysis 

The test strip market trends is steady over the forecast period. Various factors lead to the high growth of the test strip market. The driving factors of the market are governmental support. Also, the prevalence of chronic illness brings favourable changes in the market. The stringent governmental policies are problematic for the market.

Also, a lack of awareness about test strips is affecting growth. However, all these factors will have a slight impact on the growth trend. On the other hand, glucose test strips and urinal tract test strips segmental will have high demand. Furthermore, the growth of type 2 diabetes will contribute more to the test strip market growth. 

  • Value chain analysis 

North America is a regional player accountable high share of test strip markets. The availability of new medical technologies is another in this region. Investments in test strips are growing every year. North America will hold more than 55% of the shares in the forecast period. The governmental initiatives and adopting new health devices are potential growth factors.

The investments will streamline more research in the test strip market. The US alone records 25 million diabetes patients. Effective treatment for these patients is possible only through proper detection. Also, 90% of this population suffers from type 2 diabetes. All these factors will enhance the overall growth of the test strip market. 

Segment overview 

By application 

  • Pregnancy test 

  • Urinal analysis 

  • Florurescin 

  • Diabetic strip 

By end-user 

  • Clinics 

  • Laboratories 

  • Hospitals 

  • Consumers 

  • Diagnostic laboratories 

By region 

  • North America 

  • Asia pacific 

  • Europe 

Competitive landscape 

The competition in the test strip market is rising rapidly. There are key developments in the test strip market that will take place forecast period. The key players of the test strip market are widening their shares by improving demand in developing regions. The key strategies in the competitive landscape are market expansions, acquisitions and partnerships. 

Regional analysis 

The key regions in the competitive landscape are Asia Pacific, Europe and North America. North America is well known for its advanced medical infrastructure. The adoption of test strips is massive in this region. It is the fastest-growing region with a high potential for the product. It is a region that will mark the highest revenue rates in the test strip market.

The growth opportunities such as product launches and innovations will lead to tremendous demand. Further, Asia pacific is another largest region with rapid demand. The requirement for test strips is high due to type 2 diabetes. China is a leading player in this region that alone will have a 5.1 % growth rate. Europe will have high demand due to the prevalence of chronic illness. Alcoholic consumption and other disorders will lead to the high growth of the test strip market. 

The key players of the test strip market are 

Henry Schein

  1. Abbott, Life scan

  2. Tiadoc

  3. Acon

  4. B Braun, Siemens 

  5. Roche

  6. Bayer

  7. Arkray  

Recent developments 

  • The key players in the market are developing new test strips. These product launches will have a positive impact on the test strip market growth. 

  • Key players in Asia pacific market are enhancing their partnerships it will lead high expansion rate in the test strip market. 

Report overview 

  1. Market overview highlights 

  2. Analysis based upon COVID 19

  3. Explanation upon the Market Dynamics

  4. Value chain analysis

  5. Market segmentation overview

  6. The regional analysis

  7. Competitive landscape analysis

  8. Recent Developments 

Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   2020-2027: Substantial CAGR
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Application, Type, End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Arkray Inc., Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Chiltern Medicare Ltd, Henry Schein, Lifeassay Diagnostics (Pty), Siemens Healthcare, Taidoc Technology Corporation, and Teco Diagnostics.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Government's Support in various healthcare sectors
  • High prevalence of incidences of UTIs
  • Rising Diabetic Population, and various Technological advancements

  • Speak to Analyst Ask for Customization